Lv51
1170 积分 2020-11-13 加入
A Phase 1 study of subcutaneous toripalimab in recurrent or metastatic nasopharyngeal carcinoma
1小时前
待确认
A Phase 1 study of subcutaneous toripalimab in recurrent or metastatic nasopharyngeal carcinoma
7小时前
已完结
Comparative Cost-Effectiveness of First-Line Immunotherapy-Based Regimens for Advanced Triple-Negative Breast Cancer
6天前
已完结
Recombinant human hyaluronidase (rHuPH20): an enabling platform for subcutaneous drug and fluid administration
7天前
已完结
Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysis
1个月前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
5个月前
已完结
The impact of low HER2 expression on clinicopathological features and clinical outcomes in patients with metastatic gastric cancer
5个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
6个月前
已关闭
Efficacy, Safety, and Biomarker Analysis of Toripalimab Monoclonal Antibody Combined with Gemcitabine and Cisplatin Chemotherapy as Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: A Phase II Clinical Trial
6个月前
已完结
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
6个月前
已完结
皖公网安备34019202002308
